Legal status · United States
Is Niacin legal in the United States?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
Yes. Niacin is an approved medicine in the United States, classified as "FDA-approved prescription lipid drug, also sold over the counter as a supplement". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. On the evidence, 5 human studies are cited on its profile.
Niacin in the United States at a glance
| Classification | FDA-approved prescription lipid drug, also sold over the counter as a supplement |
|---|---|
| Note | Guideline use for cardiovascular prevention has effectively ended following AIM-HIGH and HPS2-THRIVE. Supplement-dose nicotinic acid remains freely available. |
| FDA approval status | Extended-release nicotinic acid is an FDA-approved prescription lipid drug in the United States, though its clinical use collapsed after AIM-HIGH and HPS2-THRIVE. Lower-dose nicotinic acid is also sold over the counter as a supplement. The extended-release niacin with laropiprant combination used in HPS2-THRIVE was withdrawn worldwide after the trial reported. |
| Human studies cited | 5 of 6 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the Niacin profile, checked against U.S. Food and Drug Administration (FDA) listings at the reviewed date.
What this means
- 01
FDA has approved Niacin for at least one labeled indication, so a pharmaceutical-grade product exists in the United States and is dispensed on prescription.
- 02
Approval is indication-specific. Uses outside the label are a clinical decision for a prescriber, not something the approval itself authorizes.
- 03
Unlicensed online vials, including those labeled "research use only", are not the approved product and are not covered by the approval.
What Niacin is
The only compound in the NAD pathway ever tested against hard cardiovascular outcomes, in 25,673 patients in HPS2-THRIVE and 3,414 in AIM-HIGH. It moved every lipid it was supposed to move and prevented no events in either trial, and HPS2-THRIVE found excess serious adverse events including infection and bleeding.
If you want to understand why a moving biomarker is not evidence, this is the compound to study. Nothing else in the longevity supplement world has been tested this thoroughly against outcomes that actually matter, and the answer came back twice.
Mechanism: Nicotinic acid enters NAD synthesis through the Preiss-Handler pathway rather than the NAMPT salvage route, which is why it is a genuinely potent NAD booster and why a 2026 human study proposed that gut bacterial conversion of NR and NMN into nicotinic acid may be how those two expensive precursors work at all. Its lipid effects are separate and act mainly through inhibition of adipocyte lipolysis and hepatic diacylglycerol acyltransferase, reducing free fatty acid flux to the liver and VLDL output.
Regulatory history: Extended-release nicotinic acid is an FDA-approved prescription lipid drug in the United States, though its clinical use collapsed after AIM-HIGH and HPS2-THRIVE. Lower-dose nicotinic acid is also sold over the counter as a supplement. The extended-release niacin with laropiprant combination used in HPS2-THRIVE was withdrawn worldwide after the trial reported.
How FDA treats this kind of product
Approves prescription drugs by indication and polices unapproved products, including peptides sold online. Compounding pharmacies may prepare some compounds under a prescription when the FDA places them on a permitted bulk-substances category.
The classification above is the The Longevity Archive reading of U.S. Food and Drug Administration listings for Niacin at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Niacin in other countries
United Kingdom
Not approvedAvailable as a supplement; the extended-release niacin plus laropiprant product was withdrawn
Is Niacin legal in the United Kingdom?Australia
Not approvedAvailable as a supplement; prescription lipid indication largely abandoned
Is Niacin legal in Australia?Canada
Not approvedPrescription extended-release product historically available; also sold as a supplement
Is Niacin legal in Canada?Frequently asked questions
Is Niacin legal in the United States?
Yes. Niacin is an approved medicine in the United States, classified as "FDA-approved prescription lipid drug, also sold over the counter as a supplement". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. On the evidence, 5 human studies are cited on its profile. Note: Guideline use for cardiovascular prevention has effectively ended following AIM-HIGH and HPS2-THRIVE. Supplement-dose nicotinic acid remains freely available.
Can I buy Niacin in the United States?
Only with a prescription. Niacin is classified as "FDA-approved prescription lipid drug, also sold over the counter as a supplement" in the United States, so it is dispensed by pharmacies against a prescription for its approved indication. Buying it from unlicensed online sellers or as a "research chemical" is outside that system and carries no regulatory protection. Note: Guideline use for cardiovascular prevention has effectively ended following AIM-HIGH and HPS2-THRIVE. Supplement-dose nicotinic acid remains freely available.
Is Niacin FDA approved?
Yes. FDA status: Extended-release nicotinic acid is an FDA-approved prescription lipid drug in the United States, though its clinical use collapsed after AIM-HIGH and HPS2-THRIVE. Lower-dose nicotinic acid is also sold over the counter as a supplement. The extended-release niacin with laropiprant combination used in HPS2-THRIVE was withdrawn worldwide after the trial reported.. Current US classification: "FDA-approved prescription lipid drug, also sold over the counter as a supplement". On the evidence, 5 human studies are cited on its profile.
Related compounds in the United States
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Niacin live on its compound profile.
Niacin profileThis page is general information about the regulatory status of Niacin in the United States, current as of Sep 2026. It is not legal advice, and classifications change; check U.S. Food and Drug Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.